Profile picture

Doctor Ziqin Zhou

Guangdong Cardiovascular Institute, Guangzhou (China)
Membership: ESC Professional Member
Follow
Logo ESC

Contributor content

A targeted and safe strategy for post-infarction anti-inflammatory therapy: cardiac-restricted NLRP3 inhibition via a biomimetic nanocarrier
Presentation
A targeted and safe strategy for post-infarction anti-inflammatory therapy: cardiac-restricted NLRP3 inhibition via a biomimetic nanocarrier
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources